Literature DB >> 27538595

MicroRNAs-424 and 206 are potential prognostic markers in spinal onset amyotrophic lateral sclerosis.

Helen M T de Andrade1, Milena de Albuquerque1, Simoni H Avansini2, Cristiane de S Rocha2, Danyella B Dogini2, Anamarli Nucci1, Benilton Carvalho2, Iscia Lopes-Cendes2, Marcondes C França3.   

Abstract

INTRODUCTION: Skeletal muscle microRNAs (miRNAs) are potential candidate biomarkers for amyotrophic lateral sclerosis (ALS) that deserve further investigation.
OBJECTIVES: To identify miRNAs abnormally expressed in the skeletal muscle and plasma of patients with ALS, and to correlate them with parameters of disease progression.
METHODS: Expression profile of miRNAs in muscle was evaluated using an array platform. Subsequently we assessed the plasmatic expression of candidate miRNAs in a set of 39 patients/39 controls. We employed generalized estimating equations to investigate correlations with clinical data.
RESULTS: We identified 11 miRNAs differentially expressed in the muscle of ALS patients; of these, miR424, miR-214 and miR-206 were validated by qPCR in muscle samples. In plasma, we found only miR-424 and miR 206 to be overexpressed. Baseline expression of miR-424 and 206 correlated with clinical deterioration over time.
CONCLUSION: MiR-424 and miR-206 are potential prognostic markers for ALS.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; MicroRNA; Motor neuron; Prognosis; Skeletal muscle

Mesh:

Substances:

Year:  2016        PMID: 27538595     DOI: 10.1016/j.jns.2016.06.046

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  28 in total

1.  Two distinct skeletal muscle microRNA signatures revealing the complex mechanism of sporadic ALS.

Authors:  Evrim Aksu-Menges; Burcu Balci-Hayta; Can Ebru Bekircan-Kurt; Ayse Tulay Aydinoglu; Sevim Erdem-Ozdamar; Ersin Tan
Journal:  Acta Neurol Belg       Date:  2021-07-09       Impact factor: 2.396

2.  The Role of MicroRNAs in Patients with Amyotrophic Lateral Sclerosis.

Authors:  Efthimios Dardiotis; Athina-Maria Aloizou; Vasileios Siokas; George P Patrinos; Georgia Deretzi; Panayiotis Mitsias; Michael Aschner; Aristidis Tsatsakis
Journal:  J Mol Neurosci       Date:  2018-11-10       Impact factor: 3.444

Review 3.  Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis.

Authors:  Lucas T Vu; Robert Bowser
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

4.  Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosis.

Authors:  Iddo Magen; Nancy Sarah Yacovzada; Eran Yanowski; Anna Coenen-Stass; Julian Grosskreutz; Ching-Hua Lu; Linda Greensmith; Andrea Malaspina; Pietro Fratta; Eran Hornstein
Journal:  Nat Neurosci       Date:  2021-10-28       Impact factor: 24.884

Review 5.  Stress-induced changes in miRNA biogenesis and functioning.

Authors:  Marta Olejniczak; Anna Kotowska-Zimmer; Wlodzimierz Krzyzosiak
Journal:  Cell Mol Life Sci       Date:  2017-07-17       Impact factor: 9.261

Review 6.  miRNA in spinal muscular atrophy pathogenesis and therapy.

Authors:  Francesca Magri; Fiammetta Vanoli; Stefania Corti
Journal:  J Cell Mol Med       Date:  2017-11-21       Impact factor: 5.310

Review 7.  MotomiRs: miRNAs in Motor Neuron Function and Disease.

Authors:  Zachary C E Hawley; Danae Campos-Melo; Cristian A Droppelmann; Michael J Strong
Journal:  Front Mol Neurosci       Date:  2017-05-04       Impact factor: 5.639

8.  MicroRNA-5572 Is a Novel MicroRNA-Regulating SLC30A3 in Sporadic Amyotrophic Lateral Sclerosis.

Authors:  Hisaka Kurita; Saori Yabe; Tomoyuki Ueda; Masatoshi Inden; Akiyoshi Kakita; Isao Hozumi
Journal:  Int J Mol Sci       Date:  2020-06-24       Impact factor: 5.923

9.  An miRNA fingerprint using neural-enriched extracellular vesicles from blood plasma: towards a biomarker for amyotrophic lateral sclerosis/motor neuron disease.

Authors:  Sandra Anne Banack; Rachael Anne Dunlop; Paul Alan Cox
Journal:  Open Biol       Date:  2020-06-24       Impact factor: 6.411

10.  Identification of a potential non-coding RNA biomarker signature for amyotrophic lateral sclerosis.

Authors:  Greig Joilin; Elizabeth Gray; Alexander G Thompson; Yoana Bobeva; Kevin Talbot; Jochen Weishaupt; Albert Ludolph; Andrea Malaspina; P Nigel Leigh; Sarah F Newbury; Martin R Turner; Majid Hafezparast
Journal:  Brain Commun       Date:  2020-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.